Neil Minkoff, MD: As we’re starting to wind down a little, I want to make sure something that was touched on doesn’t fly under the radar. A few people talked about the appropriate next step for ...

Polyneuropathy (PNP) remains a common comorbidity among patients with chronic obstructive pulmonary disease (COPD), and better screening strategies are needed to identify the condition and improve ...

The US Preventive Services Task Force (USPSTF) found after a reaffirmation process that there was no net benefit to screening asymptomatic adults for chronic obstructive pulmonary disease (COPD).

Jan. 11 (UPI) --People at high risk for a common breathing disorder can be identified in less than eight minutes using simple screening tools, a study published Tuesday by JAMA found. A patient ...

"Screening tools for COPD have been shown to have reasonable diagnostic accuracy in high-income countries, but due to better population health and treatment in these settings, this has tended to ...

COPD, as the sixth leading cause of death in the US, is widely seen as a preventable epidemic. However, shortcomings in public policy and healthcare hinder access to timely and accurate diagnosis, as ...

Doctors could soon have a new tool to help diagnose chronic obstructive pulmonary disease (COPD). A questionnaire called CAPTURE successfully identified almost half of clinical trial participants who ...

COPD remains one of India's most underdiagnosed lung diseases, with millions noticing symptoms only after serious damage.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The 2024 GOLD report newly highlights hyperinflation, ...

Among asymptomatic adults who underwent lung cancer screening, risks for all-cause, COPD and cardiovascular disease mortality ...

Zein became aware of alcohol’s impact on COPD a few years ago. In a paper published in 2021, Zein and colleagues found that ...

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced the completion of its Phase IIa clinical study for 9MW1911, a self-developed ...